| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 490 | $150 | $72.3K |
| J2562 | Injection, plerixafor, 1 mg | 360 | $150 | $55.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 440 | $100 | $44.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $100 | $21.2K |
| 36522 | The provider performs extracorporeal photopheresis, a medical procedure in which a patient's white blood cells are exposed first to a drug called 8–methoxypsoralen (8–MOP) and then to ultraviolet A… | 120 | $70 | $8.9K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 50 | $150 | $7.5K |
| 99239 | The provider sees a patient for hospital inpatient or observation discharge day management, involving evaluation and management (E/M). The provider spends more than 30 minutes on the service on the… | 30 | $100 | $3.2K |
| 38206 | The provider harvests hematopoietic progenitor cells (HPCs) from a patient’s own blood using a technique known as apheresis. The provider performs this service using specially designed equipment for… | 40 | $70 | $3K |
| 38221 | The provider takes one or more samples of bone marrow from the sternum or pelvic bone for diagnostic purposes only. | 20 | $150 | $2.5K |
| 38241 | In this procedure, the provider introduces into a patient’s blood stream the hematopoietic progenitor cells, or HPCs, which he harvests directly from the patient. | 20 | $150 | $2.3K |